Original Literature | Model OverView |
---|---|
Publication
Title
Signaling to NF-kappaB by Toll-like receptors.
Affiliation
Department of Host Defense and Exploratory Research for Advanced Technology,Japan Science and Technology Agency, Research Institute for Microbial Diseases,Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
Abstract
Innate immunity is the first line of defense against invading pathogens. Afamily of Toll-like receptors (TLRs) acts as primary sensors that detect a widevariety of microbial components and elicit innate immune responses. All TLRsignaling pathways culminate in activation of the transcription factor nuclearfactor-kappaB (NF-kappaB), which controls the expression of an array ofinflammatory cytokine genes. NF-kappaB activation requires the phosphorylationand degradation of inhibitory kappaB (IkappaB) proteins, which is triggered bytwo kinases, IkappaB kinase alpha (IKKalpha) and IKKbeta. In addition, severalTLRs activate alternative pathways involving the IKK-related kinases TBK1 [TRAFfamily member-associated NF-kappaB activator (TANK) binding kinase-1] and IKKi,which elicit antiviral innate immune responses. Here, we review recent progressin our understanding of the role of NF-kappaB in TLR signaling pathways anddiscuss potential implications for molecular medicine.
PMID
18029230
|
Entity
Process
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m46
10
infinite
0
TRANSPATH | MO000000058 |
--
RIP1{ub}
--
MO000000065
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m83
10
infinite
0
InterPro | IPR000198 |
TRANSPATH | MO000000065 |
--
MAPKs
--
MO000000077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m76
10
infinite
0
TRANSPATH | MO000000077 |
--
p100{p}
--
MO000000202
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m173
10
infinite
0
TRANSPATH | MO000000202 |
--
IKK-alpha
--
MO000000210
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m181
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
IKK-beta
--
MO000000211
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m182
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000211 |
--
IKK{active}
--
MO000000248
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m207
10
infinite
0
TRANSPATH | MO000000248 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
TAK1
--
MO000016574
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1573
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016574 |
--
IKK-gamma
--
MO000016599
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1593
10
infinite
0
InterPro | IPR007087 |
TRANSPATH | MO000016599 |
--
IKK-i
--
MO000016608
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1599
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016608 |
--
Caspase-8/10
--
MO000016900
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1815
10
infinite
0
TRANSPATH | MO000016900 |
--
TRAF3
--
MO000016963
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1872
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000016963 |
--
TBK1
--
MO000019331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3902
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
TLR4
--
MO000019394
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3961
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019394 |
--
TLR2
--
MO000019397
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3964
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019397 |
--
TLR5
--
MO000019399
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3966
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019399 |
--
flagellin
--
MO000022185
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m6485
10
infinite
0
TRANSPATH | MO000022185 |
--
TIRAP
--
MO000022528
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6810
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000022528 |
--
IRAK-4
--
MO000039077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17258
10
infinite
0
TRANSPATH | MO000039077 |
--
TRIF
--
MO000041125
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18998
10
infinite
0
TRANSPATH | MO000041125 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
IRF7{p}:IRF7{p}
--
e100
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m104
0
infinite
0
--
IFN-alpha
--
e101
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m105
0
infinite
0
--
TLR1:TLR2:Triacyl lipopeptides
--
e102
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m106
0
infinite
0
--
TLR1:TLr2:Triacyllioppeptides:TIRAP:MyD88
--
e103
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m107
0
infinite
0
--
TLR1:TLr2:Triacyllioppeptides:TIRAP:MyD88:IRAK-4
--
e104
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m108
0
infinite
0
--
TLR1:TLr2:Triacyllioppeptides:TIRAP:MyD88:IRAK-4{p}
--
e105
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m109
0
infinite
0
--
TLR1:TLr2:Triacyllioppeptides:TIRAP:MyD88:IRAK-4{p}:IRAK1
--
e106
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m110
0
infinite
0
--
TLR1:TLr2:Triacyllioppeptides:TIRAP:MyD88:IRAK-4{p}:IRAK1{p}
--
e107
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m111
0
infinite
0
--
IRAK-4{p}:IRAK1{p}
--
e108
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m112
0
infinite
0
--
IRAK4{p}:IRAK1{p}:TRAF6
--
e109
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m113
0
infinite
0
--
TLR2:Lipoarabinomannan:TLR2
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
LPS;TLR4:TIRAP:MyD88:IRAK-4
--
e110
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m114
0
infinite
0
--
LPS;TLR4:TIRAP:MyD88:IRAK-4{p}
--
e111
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m115
0
infinite
0
--
LPS;TLR4:TIRAP:MyD88:IRAK-4{p}:IRAK1
--
e112
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m116
0
infinite
0
--
LPS;TLR4:TIRAP:MyD88:IRAK-4{p}:IRAK1{p}
--
e113
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m117
0
infinite
0
--
cyclohexamide
--
e114
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m118
0
infinite
0
--
TNF-alpha receptor
--
e115
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m119
0
infinite
0
--
TNF-alpha:receptor
--
e116
cso30:c:Complex
cso30:i:CC_NuclearOuterMembrane
--
--
csml-variable:Double
m120
0
infinite
0
--
RIG-1
--
e117
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m121
0
infinite
0
--
Mda5
--
e118
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m122
0
infinite
0
--
IPS-1
--
e119
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m123
0
infinite
0
--
Hemagglutinin
--
e12
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
RIG-1:IPS-1:RNA:FADD:Caspase 8/10,TRA:F3:NEMO
--
e120
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m124
0
infinite
0
--
RIG-1:RNA:IPS-1
--
e121
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m125
0
infinite
0
--
Mda5:IPS-1:RNA:FADD:Caspase 8/10,TRA:F3:NEMO
--
e122
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m126
0
infinite
0
--
RNA
--
e123
cso30:c:mRNA
cso30:i:CC_Extracellular
--
csml-variable:Double
m127
0
infinite
0
--
RIG-1:RNA
--
e124
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m128
0
infinite
0
--
Mda5:RNA
--
e125
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m129
0
infinite
0
--
Mda5:RNA:IPS-1
--
e126
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m130
0
infinite
0
--
dsDNA
--
e128
cso30:c:Dna
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m132
0
infinite
0
--
csml-variable:Double
m133
0
infinite
0
--
Hemagglutinin:TLR2
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m13
0
infinite
0
--
ZBP1:dsDNA:TBK1:IKKi
--
e130
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m134
0
infinite
0
--
IRF7{p}
--
e131
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m135
0
infinite
0
--
ubiquitin
--
e132
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m136
0
infinite
0
--
IKK-beta{p}
--
e133
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m137
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000211 |
--
p50
--
e134
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m138
0
infinite
0
--
Ikk-alpha:IKK-alpha
--
e135
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m139
0
infinite
0
--
p52:RelB
--
e137
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m141
0
infinite
0
--
mRNA
--
e138
cso30:c:mRNA
cso30:i:CC_Nucleolus
--
--
csml-variable:Double
m142
0
infinite
0
--
TRAF6{ub}:TABs:TAK1
--
e139
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m143
0
infinite
0
--
tGPI-mutin
--
e14
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
IKK-gamma{ub}:TABs:TAK1
--
e140
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m144
0
infinite
0
--
RIP1:TRAF6:TAK1:TRIF
--
e141
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m145
0
infinite
0
--
tGPI-mutin:TLR2
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m15
0
infinite
0
--
TLR2:TLR1
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
Triacyl lipopeptide:TLR1:TLR2
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
Tri-acyl Lipopeptide
--
e18
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
TLR2:TLR6
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
Diacyl lipopeptide:TLR2:TLR6
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
Di-acyl Lipopeptide
--
e21
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m21
0
infinite
0
--
LPS:TLR4
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
MPLA
--
e23
cso30:c:SmallMolecule
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m23
0
infinite
0
--
MPLA:TLR4
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
Envelope protein
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
Envelope protein:TLR4
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
Flagellin:TLR5
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m27
0
infinite
0
--
Lamina Propria
--
e28
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
TLR5:Lamina Propria
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Uropathogenic bacteria components
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
TLR11:Uropathogenic components
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
profilin like molecules
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
Profilin like molecules
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
Poly IC
--
e34
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m34
0
infinite
0
--
Poly IC:TLR3
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
ssRNA
--
e36
cso30:c:Rna
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
TLR7:ssRNA
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
Imidazoquinolines
--
e38
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
TLR7:Imidazoquinolines
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
TLR8:ssRNA
--
e40
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m40
0
infinite
0
--
TLR8:Imidazoquinolines
--
e41
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m41
0
infinite
0
--
CpG motifs
--
e42
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m42
0
infinite
0
--
TLR9:CpGmotifs
--
e43
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m43
0
infinite
0
--
Hemozoin
--
e44
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m44
0
infinite
0
--
TLR9:Hemozoin
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m45
0
infinite
0
--
csml-variable:Double
m47
0
infinite
0
--
NF-KappaB:IKappaB
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
NF-KappaB:IKappaB{p}
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
NF-KappaB:IKappaB{p}{ub}
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
--
e5
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e6
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
26s proteosome
--
e63
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m64
0
infinite
0
--
proteosome remnant
--
e64
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
NF-kappaB{active}
--
e65
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m66
10
infinite
0
TRANSPATH | MO000000058 |
--
NF-kappaB{active}
--
e66
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m67
10
infinite
0
TRANSPATH | MO000000058 |
--
LPS;TLR4:TIRAP:MyD88
--
e67
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
LPS:TLR4:TIRAP
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
TRAF6{ub}
--
e69
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m70
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m7
0
infinite
0
--
Uev1A
--
e71
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
NAK
--
e73
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m74
0
infinite
0
--
MAPKs{active}
--
e75
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m77
10
infinite
0
TRANSPATH | MO000000077 |
--
Inflammatory cytokines
--
e77
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m79
0
infinite
0
--
LPS:TLR4:TRAM
--
e78
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m80
0
infinite
0
--
LPS:TLR4:TRAM:TRIF
--
e79
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m81
0
infinite
0
--
TLR2:PGN
--
e8
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m8
0
infinite
0
--
TRIF:RIP1{ub}
--
e80
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m82
0
infinite
0
--
TRIF:TRAF6:RIP1{p}
--
e82
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
dsRNA:TLR3:TRIF
--
e83
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m86
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF3
--
e84
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m87
0
infinite
0
--
TRAF3:TBK1:IKK-i
--
e85
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m88
0
infinite
0
--
IRF-3{p}
--
e86
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m89
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRF3{p}:IRF3{p}
--
e87
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m90
0
infinite
0
--
IRF3{p}:IRF3{p}
--
e88
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m91
0
infinite
0
--
TBK1:TANK
--
e89
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m92
0
infinite
0
--
Lipoarabinomannan
--
e9
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m9
0
infinite
0
--
TBK1:IKK-i
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m93
0
infinite
0
--
csml-variable:Double
m94
0
infinite
0
--
csml-variable:Double
m95
0
infinite
0
--
TLR9:CpGmotifs:MyD88
--
e93
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m97
0
infinite
0
--
TLR9:CpGmotifs:MyD88:IRAk-4:IRAk1:TRAF6:TRAF3:IRf7
--
e94
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m98
0
infinite
0
--
IRAK1
--
e95
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m99
0
infinite
0
--
IRF7
--
e96
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m100
0
infinite
0
--
TLR9:CpGmotifs:MyD88:IRAk-4:IRAk1:TRAF6:TRAF3:IRf7{p}
--
e97
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m101
0
infinite
0
--
IRF7{p}:IRF7{p}
--
e98
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m102
0
infinite
0
--
TLR9:CpGmotifs:MyD88:IRAk-4:IRAk1:TRAF6:TRAF3
--
e99
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m103
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m155701*m3964*0.1
nodelay
--
0
PMID: 18029230 These microbial components include bacterial lipopolysaccharide (LPS; TLR4 ligand), lipoproteins (TLR2 ligand), flagellin (TLR5 ligand), bacterial CpG DNA (TLR9 ligand), viral single-stranded RNA (TLR7 ligand) and viral double-stranded RNA (TLR3 ligand) PMID: 18029230 LR2 recognizes various PAMPs, including peptidoglycan from Gram-positive bacteria, lipoarabinomannan from mycobacteria, hemagglutinin protein from measles virus and tGPI-mutin from Trypanosoma.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m3961*m23*0.1
nodelay
--
0
PMID: 18029230 TLR4 recognizes bacterial LPS and synthetic MPLA as well as envelope proteins from respiratory syncytial virus (RSV) and mouse mammary tumor virus (MMTV).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c303 : 1
stoichiometry:c304 : 1
m135*0.1
nodelay
--
0
PMID: 18029230 IPS-1 interacts with TRAF3, which subsequently activates the TBK1/IKKi?IRF3/7 axis
p101
p101
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c305 : 1
stoichiometry:c306 : 1
stoichiometry:c308 : 1
stoichiometry:c307 : 1
m136*m171*0.1
nodelay
--
0
PMID: 18029230 Ubiquitin-dependent proteolytic degradation of the C-terminal region of p105 and p100 results in the generation of mature p50 and p52
p101
p102
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c309 : 1
stoichiometry:c310 : 1
stoichiometry:c312 : 1
stoichiometry:c311 : 1
m136*m173*0.1
nodelay
--
0
PMID: 18029230 Ubiquitin-dependent proteolytic degradation of the C-terminal region of p105 and p100 results in the generation of mature p50 and p52
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c313 : 1
stoichiometry:c314 : 1
m181*0.1
nodelay
--
0
PMID: 18029230 Importantly, p100 phosphorylation is mediated by the IKKgreek small letter alpha?IKKgreek small letter alpha homodimer, which does not require IKKbeta and NEMO.
p104
p104
cso30:i:ME_Phosphorylation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c315 : 1
stoichiometry:c316 : 1
stoichiometry:c317 : 1
m139*m140*0.1
nodelay
--
0
p105
p105
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c318 : 1
stoichiometry:c319 : 1
stoichiometry:c320 : 1
m168*m167*0.1
nodelay
--
0
PMID: 18029230 p52 then forms a heterodimer with RelB to regulate expression of target genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c321 : 1
stoichiometry:c322 : 1
m141*0.1
nodelay
--
0
PMID: 18029230 p52 then forms a heterodimer with RelB to regulate expression of target genes.
p107
p107
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c324 : 1
stoichiometry:c156 : 1
stoichiometry:c325 : 1
m182*m71*0.1
nodelay
--
0
PMID: 18029230,11460167 It has been suggested that TAK1 can phosphorylate IKK¦Â and increase its enzymatic activity
p37
p108
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c328 : 1
stoichiometry:c329 : 1
stoichiometry:c330 : 1
stoichiometry:c331 : 1
stoichiometry:c332 : 1
stoichiometry:c333 : 1
m73*m1583*m6433*m1573*m19389*0.1
nodelay
--
0
PMID: 18029230,17496917 Ubiquitinated NEMO and TRAF6 subsequently recruit a protein kinase complex involving TAK1 (transforming growth factor-¦Â-activated kinase-1) and TABs (TAK1 binding proteins) (TAB1, TAB2 and TAB3), Ubiquitin-mediated activation of TAK1 and IKK, which then activates two distinct pathways involving the IKK complex and the mitogen-activated protein kinase (MAPK) (ERK, JNK, p38) pathway
p38
p109
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c335 : 1
stoichiometry:c336 : 1
m144*m75*0.1
nodelay
--
0
PMID: 18029230,17496917 Ubiquitinated NEMO and TRAF6 subsequently recruit a protein kinase complex involving TAK1 (transforming growth factor-¦Â-activated kinase-1) and TABs (TAK1 binding proteins) (TAB1, TAB2 and TAB3), Ubiquitin-mediated activation of TAK1 and IKK, which then activates two distinct pathways involving the IKK complex and the mitogen-activated protein kinase (MAPK) (ERK, JNK, p38) pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m25*m3961*0.1
nodelay
--
0
PMID: 18029230 TLR4 recognizes bacterial LPS and synthetic MPLA as well as envelope proteins from respiratory syncytial virus (RSV) and mouse mammary tumor virus (MMTV).
p39
p110
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c337 : 1
stoichiometry:c338 : 1
stoichiometry:c339 : 1
m144*m76*0.1
nodelay
--
0
PMID: 18029230,17496917 Ubiquitinated NEMO and TRAF6 subsequently recruit a protein kinase complex involving TAK1 (transforming growth factor-¦Â-activated kinase-1) and TABs (TAK1 binding proteins) (TAB1, TAB2 and TAB3), Ubiquitin-mediated activation of TAK1 and IKK, which then activates two distinct pathways involving the IKK complex and the mitogen-activated protein kinase (MAPK) (ERK, JNK, p38) pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c341 : 1
stoichiometry:c342 : 1
stoichiometry:c343 : 1
m70*m82*m1573*0.1
nodelay
--
0
PMID: 18029230,16115877 Notably, RIP1 is polyubiquitinated to form a complex with TRAF6 and TAK1, resulting in NF-¦ÊB activation
p112
p112
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c344 : 1
stoichiometry:c108 : 1
stoichiometry:c346 : 1
m145*m46*0.1
nodelay
--
0
PMID: 18029230,16115877 Notably, RIP1 is polyubiquitinated to form a complex with TRAF6 and TAK1, resulting in NF-¦ÊB activation
p113
p113
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c146 : 1
stoichiometry:c347 : 1
m74*m182*0.1
nodelay
--
0
PMID: 18029230 t has been shown that NAK enhances the enzymatic activity of IKK¦Â through direct phosphorylation, contributing to NF-¦ÊB activation.
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m6485*m3966*0.1
nodelay
--
0
PMID: 18029230 TLR5 detects bacterial flagellin expressed in intestinal epithelial cells as well as CD11c-positive lamina propria in DCs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m3966*m28*0.1
nodelay
--
0
PMID: 18029230 TLR5 detects bacterial flagellin expressed in intestinal epithelial cells as well as CD11c-positive lamina propria in DCs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m30*m19944*0.1
nodelay
--
0
PMID: 18029230 In mice, TLR11 recognizes as yet unknown components of uropathogenic bacteria, and a profilin-like molecule of Toxoplasma gondii.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m32*m33*m19944*0.1
nodelay
--
0
PMID: 18029230 In mice, TLR11 recognizes as yet unknown components of uropathogenic bacteria, and a profilin-like molecule of Toxoplasma gondii.
p16
p16
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 18029230 TLR3, 7, 8 and 9, which are localized to endosomes, detect nucleic acids derived from viruses and bacteria. PMID: 18029230 TLR3 recognizes dsRNA, which is produced by many viruses during replication, and poly IC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m34*m3965*0.1
nodelay
--
0
PMID: 18029230 TLR3, 7, 8 and 9, which are localized to endosomes, detect nucleic acids derived from viruses and bacteria. PMID: 18029230 TLR3 recognizes dsRNA, which is produced by many viruses during replication, and poly IC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m19940*m36*0.1
nodelay
--
0
PMID: 18029230 TLR7 recognizes ssRNA derived from various viruses and synthetic imidazoquinolines with antitumor properties.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m19940*m38*0.1
nodelay
--
0
PMID: 18029230 TLR7 recognizes ssRNA derived from various viruses and synthetic imidazoquinolines with antitumor properties.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m3964*m9*0.1
nodelay
--
0
PMID: 18029230 These microbial components include bacterial lipopolysaccharide (LPS; TLR4 ligand), lipoproteins (TLR2 ligand), flagellin (TLR5 ligand), bacterial CpG DNA (TLR9 ligand), viral single-stranded RNA (TLR7 ligand) and viral double-stranded RNA (TLR3 ligand) PMID: 18029230 LR2 recognizes various PAMPs, including peptidoglycan from Gram-positive bacteria, lipoarabinomannan from mycobacteria, hemagglutinin protein from measles virus and tGPI-mutin from Trypanosoma.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m36*m19823*0.1
nodelay
--
0
PMID:18029230 Human TLR8 also participates in the recognition of ssRNA and imidazoquinolines, whereas the function of mouse TLR8 remains unclear.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m38*m19823*0.1
nodelay
--
0
PMID:18029230 Human TLR8 also participates in the recognition of ssRNA and imidazoquinolines, whereas the function of mouse TLR8 remains unclear.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m42*m19828*0.1
nodelay
--
0
PMID: 18029230 LR9 recognizes CpG DNA motifs present in bacterial and viral genomes as well as non-nucleic acids such as hemozoin from Plasmodium.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m44*m19828*0.1
nodelay
--
0
PMID: 18029230 LR9 recognizes CpG DNA motifs present in bacterial and viral genomes as well as non-nucleic acids such as hemozoin from Plasmodium.
p24
p24
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m166*m47*0.1
nodelay
--
0
PMID: 18029230,17072327 The most frequently activated form of NF-¦ÊB in TLR signaling is a heterodimer composed of RelA and p50
p25
p25
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m46*m186*0.1
nodelay
--
0
PMID: 18029230 Under unstimulated conditions, NF-¦ÊB is sequestered in the cytoplasm as an inactive form by interaction with a family of inhibitor proteins known as I¦ÊB proteins PMID: 18029230 The RelA?p50 heterodimer is kept in the cytoplasm as a latent and inactive form by interaction with I¦ÊB proteins in unstimulated cells
p26
p26
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m1593*m182*m181*0.1
nodelay
--
0
PMID: 18029230 Stimulation with TLR ligands triggers the rapid phosphorylation of specific serine residues of I¦ÊB proteins by a multiprotein complex termed the IKK complex, which consists of two catalytic components, IKKgreek small letter alpha and IKK¦Â, and a regulatory component, NEMO (NF-¦ÊB essential modifier, also known as IKK¦Ã).
p27
p27
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m207*m48*0.1
nodelay
--
0
PMID: 18029230 Stimulation with TLR ligands triggers the rapid phosphorylation of specific serine residues of I¦ÊB proteins by a multiprotein complex termed the IKK complex, which consists of two catalytic components, IKKgreek small letter alpha and IKK¦Â, and a regulatory component, NEMO (NF-¦ÊB essential modifier, also known as IKK¦Ã).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m49*0.1
nodelay
--
0
PMID: 18029230 Phosphorylated I¦ÊB proteins are subsequently polyubiquitinated and degraded by the 26S proteasome, allowing NF-¦ÊB to move into the nucleus.
p29
p29
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m63*m64*0.1
nodelay
--
0
PMID: 18029230 Phosphorylated I¦ÊB proteins are subsequently polyubiquitinated and degraded by the 26S proteasome, allowing NF-¦ÊB to move into the nucleus.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c7 : 1
m12*m3964*0.1
nodelay
--
0
PMID: 18029230 These microbial components include bacterial lipopolysaccharide (LPS; TLR4 ligand), lipoproteins (TLR2 ligand), flagellin (TLR5 ligand), bacterial CpG DNA (TLR9 ligand), viral single-stranded RNA (TLR7 ligand) and viral double-stranded RNA (TLR3 ligand) PMID: 18029230 LR2 recognizes various PAMPs, including peptidoglycan from Gram-positive bacteria, lipoarabinomannan from mycobacteria, hemagglutinin protein from measles virus and tGPI-mutin from Trypanosoma.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m66*0.1
nodelay
--
0
PMID: 18029230 Phosphorylated I¦ÊB proteins are subsequently polyubiquitinated and degraded by the 26S proteasome, allowing NF-¦ÊB to move into the nucleus.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m67*0.1
nodelay
--
0
PMID: 18029230,17072327 This pathway is called the ¡Æcanonical pathway¡Ç and is responsible for TLR-mediated induction of inflammatory cytokines such as tumor necrosis factor-greek small letter alpha (TNF-greek small letter alpha) and IL-6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m67*0.1
nodelay
--
0
PMID: 18029230,17072327 This pathway is called the ¡Æcanonical pathway¡Ç and is responsible for TLR-mediated induction of inflammatory cytokines such as tumor necrosis factor-greek small letter alpha (TNF-greek small letter alpha) and IL-6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m22*m6810*0.1
nodelay
--
0
PMID: 18029230 TLR4 uses four adaptors, MyD88, TIRAP, TRIF and TRAM. TLR3 uses TRIF as the sole adaptor PMID: 18029230
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m1572*m69*0.1
nodelay
--
0
PMID: 18029230 TLR4 uses four adaptors, MyD88, TIRAP, TRIF and TRAM. TLR3 uses TRIF as the sole adaptor PMID: 18029230
p46
p35
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c137 : 1
stoichiometry:c140 : 1
m18998*m183*m83*0.1
nodelay
--
0
PMID: 18029230,15064760 he TRIF C-terminal region contains the Rip homotypic interaction motif (RHIM), which is responsible for interaction with RIP1 (receptor-interacting protein-1), a member of the RIP family involved in TNF-receptor-mediated NF-¦ÊB activation 29 E. Meylan et al., RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappaB activation
p35
p36
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c348 : 1
stoichiometry:c107 : 1
m1593*m72*m6443*m113*0.1
nodelay
--
0
PMID: 18029230,17496917,16858426 TRAF6 is a RING-domain E3 ubiquitin ligase, and together with E2, Ubc13 and Uev1A, it promotes Lys63-linked polyubiquitination of target proteins, including TRAF6 itself and NEMO
p37
p37
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c323 : 1
stoichiometry:c326 : 1
stoichiometry:c101 : 1
stoichiometry:c327 : 1
m6433*m1573*m19389*m1583*m70*0.1
nodelay
--
0
PMID: 18029230,17496917 Ubiquitinated NEMO and TRAF6 subsequently recruit a protein kinase complex involving TAK1 (transforming growth factor-¦Â-activated kinase-1) and TABs (TAK1 binding proteins) (TAB1, TAB2 and TAB3), Ubiquitin-mediated activation of TAK1 and IKK, which then activates two distinct pathways involving the IKK complex and the mitogen-activated protein kinase (MAPK) (ERK, JNK, p38) pathway
p38
p38
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c334 : 1
stoichiometry:c116 : 1
m75*m143*0.1
nodelay
--
0
PMID: 18029230 The activated TAK1 complex then activates the IKK complex consisting of IKKgreek small letter alpha, IKK¦Â and NEMO, which catalyzes the phosphorylation of I¦ÊB proteins (P)
p39
p39
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c118 : 1
stoichiometry:c120 : 1
m76*m143*0.1
nodelay
--
0
PMID: 18029230 Simultaneously, the TAK1 complex activates the MAPK pathway, which results in the phosphorylation (P) and activation of AP-1 PMID: 18029230,17496917 Ubiquitinated NEMO and TRAF6 subsequently recruit a protein kinase complex involving TAK1 (transforming growth factor-¦Â-activated kinase-1) and TABs (TAK1 binding proteins) (TAB1, TAB2 and TAB3), Ubiquitin-mediated activation of TAK1 and IKK, which then activates two distinct pathways involving the IKK complex and the mitogen-activated protein kinase (MAPK) (ERK, JNK, p38) pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m14*m15*m3964*0.1
nodelay
--
0
PMID: 18029230 These microbial components include bacterial lipopolysaccharide (LPS; TLR4 ligand), lipoproteins (TLR2 ligand), flagellin (TLR5 ligand), bacterial CpG DNA (TLR9 ligand), viral single-stranded RNA (TLR7 ligand) and viral double-stranded RNA (TLR3 ligand) PMID: 18029230 LR2 recognizes various PAMPs, including peptidoglycan from Gram-positive bacteria, lipoarabinomannan from mycobacteria, hemagglutinin protein from measles virus and tGPI-mutin from Trypanosoma.
p40
p40
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m77*m15167*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m78*0.1
nodelay
--
0
PMID: 18029230 NF-¦ÊB and AP-1 control inflammatory responses through the induction of inflammatory cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m67*0.1
nodelay
--
0
PMID: 18029230 NF-¦ÊB and AP-1 control inflammatory responses through the induction of inflammatory cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m22*m19005*0.1
nodelay
--
0
PMID: 18029230 TIRAP and TRAM are required for the activation of the MyD88- and the TRIF-dependent pathways, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c131 : 1
stoichiometry:c133 : 1
m18998*m80*0.1
nodelay
--
0
PMID: 18029230 TIRAP and TRAM are required for the activation of the MyD88- and the TRIF-dependent pathways, respectively.
p46
p46
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c340 : 1
stoichiometry:c139 : 1
m83*m18998*0.1
nodelay
--
0
PMID: 18029230,15064760 he TRIF C-terminal region contains the Rip homotypic interaction motif (RHIM), which is responsible for interaction with RIP1 (receptor-interacting protein-1), a member of the RIP family involved in TNF-receptor-mediated NF-¦ÊB activation 29 E. Meylan et al., RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappaB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c142 : 1
m84*0.1
nodelay
--
0
PMID: 18029230,16115877 Notably, RIP1 is polyubiquitinated to form a complex with TRAF6 and TAK1, resulting in NF-¦ÊB activation
p48
p48
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c144 : 1
stoichiometry:c155 : 1
m85*m1573*0.1
nodelay
--
0
PMID:18029230 These findings indicate that TRIF recruits TRAF6 and RIP1 via distinct regions and that these molecules appear to cooperative to facilitate TAK1 activation, resulting in robust NF-¦ÊB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
m46*0.1
nodelay
--
0
PMID:18029230 These findings indicate that TRIF recruits TRAF6 and RIP1 via distinct regions and that these molecules appear to cooperative to facilitate TAK1 activation, resulting in robust NF-¦ÊB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m3964*m3963*0.1
nodelay
--
0
p50
p50
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m18998*m19314*0.1
nodelay
--
0
PMID: 18029230 TLR3 uses TRIF as the sole adaptor.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m86*m1872*0.1
nodelay
--
0
PMID: 18029230 TRIF recruits TRAF3, which then interacts with TBK1 and IKKi.
p53
p53
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m88*m977*0.1
nodelay
--
0
PMID: 18029230 These kinases mediate phosphorylation of IRF3 (P). Phosphorylated IRF3 dimerizes and translocates into the nucleus to regulate transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
m89*0.1
nodelay
--
0
PMID: 18029230 These kinases mediate phosphorylation of IRF3 (P). Phosphorylated IRF3 dimerizes and translocates into the nucleus to regulate transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c165 : 1
m90*0.1
nodelay
--
0
PMID: 18029230 These kinases mediate phosphorylation of IRF3 (P). Phosphorylated IRF3 dimerizes and translocates into the nucleus to regulate transcription
p56
p56
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c175 : 1
stoichiometry:c176 : 1
stoichiometry:c167 : 1
m91*m96*m67*0.1
nodelay
--
0
PMID: 18029230 These kinases mediate phosphorylation of IRF3 (P). Phosphorylated IRF3 dimerizes and translocates into the nucleus to regulate transcription PMID: 18029230,16979567 n the nucleus, IRF3 together with NF-¦ÊB and ATF2/c-Jun form a multiprotein complex called an enhanceosome, which binds the promoter?enhancer region of the IFN-¦Â gene
p57
p57
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c169 : 1
stoichiometry:c170 : 1
m3897*m3902*0.1
nodelay
--
0
PMID: 18029230 TBK1 was identified as a protein kinase interacting with TANK (also known as I-TRAF), a TRAF-binding protein
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c171 : 1
stoichiometry:c269 : 1
stoichiometry:c270 : 1
m87*m93*0.1
nodelay
--
0
PMID: 18029230 TRIF recruits TRAF3, which then interacts with TBK1 and IKKi.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c173 : 1
stoichiometry:c174 : 1
m91*m95*0.1
nodelay
--
0
PMID: 18029230 This allows IRF3 to form a homodimer, translocate into the nucleus and bind its target sequences, such as IFN-stimulated response element (ISRE).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m18*m16*0.1
nodelay
--
0
PMID: 18029230 These microbial components include bacterial lipopolysaccharide (LPS; TLR4 ligand), lipoproteins (TLR2 ligand), flagellin (TLR5 ligand), bacterial CpG DNA (TLR9 ligand), viral single-stranded RNA (TLR7 ligand) and viral double-stranded RNA (TLR3 ligand) PMID: 18029230 TLR2/1 and TLR2/6 discriminate the lipid structures between triacyl- and diacyl-lipopeptide, respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c178 : 1
stoichiometry:c179 : 1
m43*m1572*0.1
nodelay
--
0
PMID: 18029230 TLR1, 2 and 6 utilize MyD88 and TIRAP as adaptors while TLR5, 7, 9 and 11 utilize MyD88.
p61
p61
cso30:i:ME_Binding
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c180 : 1
stoichiometry:c181 : 1
stoichiometry:c183 : 1
stoichiometry:c184 : 1
stoichiometry:c185 : 1
stoichiometry:c186 : 1
stoichiometry:c187 : 1
stoichiometry:c182 : 1
m97*m17258*m99*m181*m70*m1872*m100*0.1
nodelay
--
0
PMID: 18029230 In pDCs, IRF7 forms a signaling complex with MyD88, IRAK4, TRAF6, IRAK1 and IKKalpha PMID: 18029230 IRAK1, but not IRAK4, physically interacts with IRF7 PMID: 18029230 TRAF3 binds to a MyD88?IRAK1?IRF7 complex and pDCs derived from TRAF3-deficient mice have defects in IFN-greek small letter alpha production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c188 : 1
stoichiometry:c189 : 1
m98*0.1
nodelay
--
0
PMID: 18029230 In response to ligand stimulation, IRF7 is phosphorylated by IRAK1 and IKKalpha
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
stoichiometry:c192 : 1
m101*0.1
nodelay
--
0
PMID: 18029230 n response to ligand stimulation, IRF7 is phosphorylated by IRAK1 and IKKgreek small letter alpha, dimerizes and is then translocated into the nucleus.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c193 : 1
stoichiometry:c194 : 1
m102*0.1
nodelay
--
0
PMID: 18029230 n response to ligand stimulation, IRF7 is phosphorylated by IRAK1 and IKKgreek small letter alpha, dimerizes and is then translocated into the nucleus.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c195 : 1
stoichiometry:c196 : 1
m104*0.1
nodelay
--
0
PMID: 18029230 IRF7 regulates the expression of type I IFNs, including IFN-greek small letter alpha and IFN-¦Â
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c197 : 1
stoichiometry:c198 : 1
m104*0.1
nodelay
--
0
PMID: 18029230 IRF7 regulates the expression of type I IFNs, including IFN-greek small letter alpha and IFN-¦Â
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c199 : 1
stoichiometry:c201 : 1
m6810*m17*0.1
nodelay
--
0
PMID: 18029230 TLR1, 2 and 6 utilize MyD88 and TIRAP as adaptors
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c203 : 1
stoichiometry:c204 : 1
m1572*m106*0.1
nodelay
--
0
PMID: 18029230 TLR1, 2 and 6 utilize MyD88 and TIRAP as adaptors
p69
p69
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c105 : 1
stoichiometry:c112 : 1
stoichiometry:c237 : 1
m46*m22*0.1
nodelay
--
0
PMID: 18029230 Pretreatment of MyD88-deficient cells with cyclohexamide, a protein synthesis inhibitor, results in an abrogation of LPS-induced NF-¦ÊB activation, thus suggesting that late phase NF-¦ÊB activation is likely to require protein synthesis. PMID: 18029230 LPS induces TNF-greek small letter alpha synthesis via a MyD88-independent mechanism, and the newly synthesized TNF-greek small letter alpha subsequently binds TNF receptor to initiate the late phase NF-¦ÊB activation in an autocrine manner, at least in MEF cells.
p6
p7
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m3964*m3987*0.1
nodelay
--
0
PMID: 18029230 These microbial components include bacterial lipopolysaccharide (LPS; TLR4 ligand), lipoproteins (TLR2 ligand), flagellin (TLR5 ligand), bacterial CpG DNA (TLR9 ligand), viral single-stranded RNA (TLR7 ligand) and viral double-stranded RNA (TLR3 ligand) PMID: 18029230 TLR2/1 and TLR2/6 discriminate the lipid structures between triacyl- and diacyl-lipopeptide, respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c205 : 1
stoichiometry:c206 : 1
stoichiometry:c207 : 1
m17258*m107*0.1
nodelay
--
0
PMID: 18029230 MyD88 recruits TRAF6 and members of the IRAK family PMID: 18029230,15229469 Upon TLR activation, through its death domain, MyD88 interacts with the death domains of members of the IRAK (IL-1 receptor-associated kinase) family of protein kinases, including IRAK1, IRAK2, IRAK4 and IRAK-M,
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c208 : 1
stoichiometry:c209 : 1
m108*0.1
nodelay
--
0
PMID: 18029230 IRAK4 is initially activated, which in turn phosphorylates and activates IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c211 : 1
stoichiometry:c212 : 1
m109*m99*0.1
nodelay
--
0
PMID: 18029230 MyD88 recruits TRAF6 and members of the IRAK family PMID: 18029230,15229469 Upon TLR activation, through its death domain, MyD88 interacts with the death domains of members of the IRAK (IL-1 receptor-associated kinase) family of protein kinases, including IRAK1, IRAK2, IRAK4 and IRAK-M,
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c214 : 1
m110*0.1
nodelay
--
0
PMID: 18029230 IRAK4 is initially activated, which in turn phosphorylates and activates IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c215 : 1
stoichiometry:c216 : 1
stoichiometry:c217 : 1
m111*0.1
nodelay
--
0
PMID: 18029230 After IRAK4 and IRAK1 have been sequentially phosphorylated, they dissociate from MyD88 and interact with TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c219 : 1
stoichiometry:c220 : 1
m112*m183*0.1
nodelay
--
0
PMID: 18029230 After IRAK4 and IRAK1 have been sequentially phosphorylated, they dissociate from MyD88 and interact with TRAF6.
p35
p76
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c221 : 1
stoichiometry:c103 : 1
stoichiometry:c109 : 1
stoichiometry:c222 : 1
m113*m6443*m72*0.1
nodelay
--
0
PMID: 18029230,17496917,16858426 TRAF6 is a RING-domain E3 ubiquitin ligase, and together with E2, Ubc13 and Uev1A, it promotes Lys63-linked polyubiquitination of target proteins, including TRAF6 itself and NEMO
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c223 : 1
stoichiometry:c224 : 1
stoichiometry:c225 : 1
m68*m17258*0.1
nodelay
--
0
PMID: 18029230 MyD88 recruits TRAF6 and members of the IRAK family PMID: 18029230,15229469 Upon TLR activation, through its death domain, MyD88 interacts with the death domains of members of the IRAK (IL-1 receptor-associated kinase) family of protein kinases, including IRAK1, IRAK2, IRAK4 and IRAK-M,
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c226 : 1
stoichiometry:c227 : 1
m114*0.1
nodelay
--
0
PMID: 18029230 IRAK4 is initially activated, which in turn phosphorylates and activates IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c228 : 1
stoichiometry:c229 : 1
stoichiometry:c230 : 1
m115*m99*0.1
nodelay
--
0
PMID: 18029230 MyD88 recruits TRAF6 and members of the IRAK family PMID: 18029230,15229469 Upon TLR activation, through its death domain, MyD88 interacts with the death domains of members of the IRAK (IL-1 receptor-associated kinase) family of protein kinases, including IRAK1, IRAK2, IRAK4 and IRAK-M,
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m21*m19*0.1
nodelay
--
0
PMID: 18029230 These microbial components include bacterial lipopolysaccharide (LPS; TLR4 ligand), lipoproteins (TLR2 ligand), flagellin (TLR5 ligand), bacterial CpG DNA (TLR9 ligand), viral single-stranded RNA (TLR7 ligand) and viral double-stranded RNA (TLR3 ligand) PMID: 18029230 TLR2/1 and TLR2/6 discriminate the lipid structures between triacyl- and diacyl-lipopeptide, respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c231 : 1
stoichiometry:c232 : 1
m116*0.1
nodelay
--
0
PMID: 18029230 IRAK4 is initially activated, which in turn phosphorylates and activates IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c233 : 1
stoichiometry:c234 : 1
stoichiometry:c235 : 1
m117*0.1
nodelay
--
0
PMID: 18029230 After IRAK4 and IRAK1 have been sequentially phosphorylated, they dissociate from MyD88 and interact with TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c239 : 1
stoichiometry:c240 : 1
m93309*0.1
nodelay
--
0
PMID: 18029230 LPS induces TNF-greek small letter alpha synthesis via a MyD88-independent mechanism, and the newly synthesized TNF-greek small letter alpha subsequently binds TNF receptor to initiate the late phase NF-¦ÊB activation in an autocrine manner, at least in MEF cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c241 : 1
stoichiometry:c242 : 1
stoichiometry:c243 : 1
m119*m230*0.1
nodelay
--
0
PMID: 18029230 LPS induces TNF-greek small letter alpha synthesis via a MyD88-independent mechanism, and the newly synthesized TNF-greek small letter alpha subsequently binds TNF receptor to initiate the late phase NF-¦ÊB activation in an autocrine manner, at least in MEF cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c246 : 1
stoichiometry:c259 : 1
stoichiometry:c250 : 1
m123*m128*0.1
nodelay
--
0
PMID: 18029230 RIG-I and Mda5 contain CARD-like structures that mediate interaction with the adaptor IPS-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c249 : 1
stoichiometry:c258 : 1
stoichiometry:c260 : 1
m123*m129*0.1
nodelay
--
0
PMID: 18029230 RIG-I and Mda5 contain CARD-like structures that mediate interaction with the adaptor IPS-1
p86
p86
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c251 : 1
stoichiometry:c261 : 1
stoichiometry:c247 : 1
stoichiometry:c252 : 1
stoichiometry:c264 : 1
stoichiometry:c265 : 1
m1872*m125*m1593*m1814*m1815*0.1
nodelay
--
0
PMID: 18029230 IPS-1 interacts with TRAF3, which subsequently activates the TBK1/IKKi?IRF3/7 axis PMID: 18029230,16585540 In parallel, IPS-1 interacts with FADD and caspase-8/-10, causing NF-¦ÊB activation PMID: 18029230,17468758 NEMO is shown to participate in both NF-¦ÊB and IRF3 activation in RIG-I and Mda5 signaling pathways
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c254 : 1
stoichiometry:c245 : 1
stoichiometry:c248 : 1
m127*m121*0.1
nodelay
--
0
PMID: 18029230 Cells express cytoplasmic RNA helicases (RIG-I and Mda5) that recognize RNA derived from actively replicating RNA viruses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c255 : 1
stoichiometry:c256 : 1
stoichiometry:c257 : 1
m127*m122*0.1
nodelay
--
0
PMID: 18029230 Cells express cytoplasmic RNA helicases (RIG-I and Mda5) that recognize RNA derived from actively replicating RNA viruses.
p86
p89
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c253 : 1
stoichiometry:c262 : 1
stoichiometry:c263 : 1
stoichiometry:c266 : 1
stoichiometry:c267 : 1
stoichiometry:c268 : 1
m1814*m1872*m1593*m130*m1815*0.1
nodelay
--
0
PMID: 18029230 IPS-1 interacts with TRAF3, which subsequently activates the TBK1/IKKi?IRF3/7 axis PMID: 18029230,16585540 In parallel, IPS-1 interacts with FADD and caspase-8/-10, causing NF-¦ÊB activation PMID: 18029230,17468758 NEMO is shown to participate in both NF-¦ÊB and IRF3 activation in RIG-I and Mda5 signaling pathways
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 18029230 These microbial components include bacterial lipopolysaccharide (LPS; TLR4 ligand), lipoproteins (TLR2 ligand), flagellin (TLR5 ligand), bacterial CpG DNA (TLR9 ligand), viral single-stranded RNA (TLR7 ligand) and viral double-stranded RNA (TLR3 ligand)
p90
p90
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c271 : 1
stoichiometry:c272 : 1
stoichiometry:c273 : 1
stoichiometry:c274 : 1
m124*m3902*m1599*0.1
nodelay
--
0
PMID:18029230 IPS-1 interacts with TRAF3, which subsequently activates the TBK1/IKKi?IRF3/7 axis
p90
p91
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c275 : 1
stoichiometry:c276 : 1
stoichiometry:c277 : 1
stoichiometry:c278 : 1
m126*m3902*m1599*0.1
nodelay
--
0
PMID:18029230 IPS-1 interacts with TRAF3, which subsequently activates the TBK1/IKKi?IRF3/7 axis
p92
p92
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c279 : 1
stoichiometry:c102 : 1
stoichiometry:c281 : 1
m124*m46*0.1
nodelay
--
0
PMID: 18029230,16585540 In parallel, IPS-1 interacts with FADD and caspase-8/-10, causing NF-¦ÊB activation
p92
p93
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c282 : 1
stoichiometry:c104 : 1
stoichiometry:c284 : 1
m126*m46*0.1
nodelay
--
0
PMID: 18029230,16585540 In parallel, IPS-1 interacts with FADD and caspase-8/-10, causing NF-¦ÊB activation
p94
p94
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c285 : 1
stoichiometry:c286 : 1
stoichiometry:c287 : 1
m1599*m1357*0.1
nodelay
--
0
PMID: 18029230 IKKi can phosphorylate a serine residue in STAT1 that is crucial for the transcriptional activity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c288 : 1
stoichiometry:c289 : 1
stoichiometry:c290 : 1
m36323*m132*0.1
nodelay
--
0
PMID: 18029230,17618271 Recently, DAI (DNA-dependent activator of interferon-regulatory factors, also known as DLM-1 and ZBP1) has been identified as a cytosolic sensor for dsDN PMID: 18029230 DAI is an IFN-inducible gene that has dsDNA-binding properties
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c291 : 1
stoichiometry:c292 : 1
stoichiometry:c293 : 1
m133*m93*0.1
nodelay
--
0
PMID: 18029230 Whereas DAI activates IRF3 via direct interactions with TBK1 and IRF3, pathways for NF-¦ÊB activation remain unknown.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c294 : 1
stoichiometry:c295 : 1
stoichiometry:c296 : 1
m134*m977*0.1
nodelay
--
0
PMID: 18029230 Whereas DAI activates IRF3 via direct interactions with TBK1 and IRF3, pathways for NF-¦ÊB activation remain unknown.
p98
p98
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c297 : 1
stoichiometry:c298 : 1
stoichiometry:c299 : 1
m93*m977*0.1
nodelay
--
0
PMID:18029230 IPS-1 interacts with TRAF3, which subsequently activates the TBK1/IKKi?IRF3/7 axis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c300 : 1
stoichiometry:c301 : 1
stoichiometry:c302 : 1
m93*m100*0.1
nodelay
--
0
PMID:18029230 IPS-1 interacts with TRAF3, which subsequently activates the TBK1/IKKi?IRF3/7 PMID: 18029230,12702806 TBK1 and IKKi can also phosphorylate and activate IRF7, which is the member of IRF family most closely related to IRF3
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--